Article
Recent advances in the design of Hedgehog pathway inhibitors for the treatment of malignancies
22 May 2014
Abstract excerpt
INTRODUCTION: The Hedgehog (Hh) signaling pathway is known to be dysregulated in several forms of cancer. Hence, specifically targeting this signaling cascade is a valid and promising strategy for successful therapeutic intervention. Several components within the Hh pathway have been proven to be druggable; however, challenges in the discovery and development process for small molecules targeting this pathway...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
